Stocksigma LogoStocksigma Logo

Aarey Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Aarey Drugs & Pharmaceuticals Ltd. has scheduled a Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results

Aarey Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Aarey Drugs & Pharmaceuticals Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Aarey Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results Aarey Drugs & Pharmaceuticals Ltd. has scheduled a Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results alongside the limited review report for the quarter and half-year ended 30th Sep'26. In compliance with SEBI Insider Trading regulations, the company's trading window closed on 1st Oct'26 and will remain shut until 48 hours following the formal announcement of the financial results.

Original exchange filing (PDF)

More announcements from Aarey Drugs & Pharmaceuticals Ltd

All Aarey Drugs & Pharmaceuticals Ltd announcements